Literature DB >> 3103919

Activation of the fibrinolytic system.

A K Robison, D Collen.   

Abstract

The fibrinolytic system is activated either directly or indirectly by proteins that convert plasminogen to plasmin in the circulation, within the interstitices, and on the surface of fibrin clots, or both. Agents that activate circulating and clot-bound plasminogen comparably induce a systemic lytic state accompanying clot lysis. Agents that activate plasminogen in the domain of fibrin preferentially exhibit clot selectivity. Fibrinolytic activators are assayed by detection of protein, generally immunologically, or of functional activity, generally by visualization of lysis of fibrin or by spectrophotometric determination of amidolytic activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103919

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.

Authors:  J C Liu; G A Peyman; M Oncel
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

2.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Authors:  Michael L Cher; Hector R Biliran; Sunita Bhagat; Yonghong Meng; Mingxin Che; Jaron Lockett; Judith Abrams; Rafael Fridman; Michael Zachareas; Shijie Sheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

3.  Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.

Authors:  Manolis C Demetriou; Michael E Pennington; Raymond B Nagle; Anne E Cress
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.